Status:
RECRUITING
An Observational Clinical Study Plan on the Effects of Radiotherapy on the Immune System of Patients With Malignant Tumors.
Lead Sponsor:
Guangzhou First People's Hospital
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18-100 years
Brief Summary
To explore the impact of radiotherapy on peripheral blood myeloid-derived suppressor cells (MDSCs), T cells and extramedullary erythroid precursor cells in patients with malignant tumors, and to evalu...
Detailed Description
To clarify the impact of radiotherapy (and/or other treatment combinations) on the proportion of myeloid-derived suppressor cells (MDSCs), T cells and extramedullary erythroid precursor cells in the p...
Eligibility Criteria
Inclusion
- Over 18 years old, diagnosed with breast cancer, nasopharyngeal cancer, colorectal cancer, cervical cancer, lung cancer, head and neck cancer and requiring radiotherapy, and the above malignant tumors have not metastasized.
- Complete inspection information.
- No other serious complications.
- No infectious diseases.
- Able and willing to take blood tests.
- All researchers gave informed consent and signed an informed consent form, which complied with the requirements of the Medical Ethics Committee.
Exclusion
- People with mental illness.
- People with autoimmune system diseases.
- Those combined with serious diseases of other organs.
- Those with severe alcoholism and drug abuse.
- Research subjects who voluntarily withdraw from the study.
Key Trial Info
Start Date :
August 8 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06202534
Start Date
August 8 2023
End Date
December 1 2024
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GuangzhouFPH
Guangzhou, Guangdong, China, 510000